The Modified Phenanthridine PJ34 Unveils an Exclusive Cell-Death Mechanism in Human Cancer Cells

This overview summarizes recent data disclosing the efficacy of the PARP inhibitor PJ34 in exclusive eradication of a variety of human cancer cells without impairing healthy proliferating cells. Its cytotoxic activity in cancer cells is attributed to the insertion of specific un-repairable anomalies...

Descripción completa

Detalles Bibliográficos
Autor principal: Cohen-Armon, Malka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7352794/
https://www.ncbi.nlm.nih.gov/pubmed/32575437
http://dx.doi.org/10.3390/cancers12061628

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7352794/
https://www.ncbi.nlm.nih.gov/pubmed/32575437
http://dx.doi.org/10.3390/cancers12061628

Ejemplares similares